Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).
about
A Dormant Microbial Component in the Development of PreeclampsiaAbnormal TREC-Based Newborn Screening Test in a Premature Neonate with Massive Perivillous Fibrin Deposition of the PlacentaPravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapyThe maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.Should We Add Pravastatin to Aspirin for Preeclampsia Prevention in High-risk Women?Dichorionic Twins Discordant for Massive Perivillous Fibrinoid Deposition: Report of a Case and Review of the Literature.Fetal death: an extreme manifestation of maternal anti-fetal rejection.Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.Pravastatin to prevent obstetrical complications in women with antiphospholipid syndrome.Placental pathologic lesions with a significant recurrence risk - what not to miss!The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).Pravastatin for the prevention of adverse pregnancy outcome: preeclampsia and more?Different Effects of Pravastatin on Preeclampsia-like Symptoms in Different Mouse Models.
P2860
Q28069689-17429BD6-3073-4081-A512-00F88D483036Q37043805-076D0484-4AC3-4270-9916-736D9A71BD98Q37137892-FE6A3E1B-0DAE-422D-9971-753D4F9374F1Q38436237-DB3F5EAC-4FFA-4DE5-BA0F-55AF07E5EF4BQ39139549-332DACD2-00E9-4F59-B0EA-15A7FBF38E85Q39425340-7C61E188-6798-4DC2-BFC8-37586620A886Q40061417-7081E041-A962-4490-8A23-6D4652317762Q41033848-E8C14891-4F22-4C03-85C4-B90F463ADBCBQ42394216-16EB25B7-D4B3-4995-842C-EE225D7F0CB6Q47546368-8045BD30-4261-4095-B544-77CCC7B28C2BQ47645647-61FF7428-5BB4-46B1-AF6B-4E604B26D7BAQ49273753-F4CD7292-58C7-48E3-9581-06512F263C94Q49941064-A9319EA0-3A6A-45AA-AAA0-B7CC5E9B204C
P2860
Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pravastatin to prevent recurre ...... sition of the placenta (MPFD).
@ast
Pravastatin to prevent recurre ...... sition of the placenta (MPFD).
@en
type
label
Pravastatin to prevent recurre ...... sition of the placenta (MPFD).
@ast
Pravastatin to prevent recurre ...... sition of the placenta (MPFD).
@en
prefLabel
Pravastatin to prevent recurre ...... sition of the placenta (MPFD).
@ast
Pravastatin to prevent recurre ...... sition of the placenta (MPFD).
@en
P2093
P2860
P50
P1476
Pravastatin to prevent recurre ...... sition of the placenta (MPFD).
@en
P2093
Alan H DeCherney
Chong Jai Kim
Edgar Hernandez-Andrade
James H Segars
M Cathleen McCoy
Piya Chaemsaithong
Sonia S Hassan
P2860
P304
P356
10.3109/14767058.2015.1022864
P577
2015-04-20T00:00:00Z